Japan Vascular Access Device Market (2026-2031)
The Japan Vascular Access Device Market was valued at $175.6 Million in 2026 and projected to reach to $230.2 Million by 2031, representing a compound annual growth rate of 5.6%. Japan's vascular access device market is positioned for steady growth, expanding from USD 175.6 million in 2026 to USD 230.2 million by 2031 at a 5.6% CAGR.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Vascular Access Device Market Trends and Insights
- Japan's aging population and rising prevalence of chronic diseases such as renal failure and cancer are driving demand for reliable vascular access solutions.
- The market in Japan benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong regulatory oversight that ensures product quality and patient safety. The vascular access device sector in Japan is characterized by steady growth driven by increasing dialysis patient populations and expanding oncology treatment centers.
- Japan's healthcare system prioritizes innovation and patient outcomes, supporting the adoption of peripheral inserted central catheters (PICCs), arteriovenous fistulas, and tunneled central venous catheters.
- Between 2026 and 2031, Japan's market will be shaped by demographic shifts, technological advancements in device design, and growing investment in healthcare infrastructure across both urban and rural regions..
Key Market Statistics
- CAGR (2026-2031) 5.6% CAGR
- Market Size, 2026 ~USD 175.6 Million
- Forecast, 2031 ~USD 230.2 Million
- Country Japan
Japan Vascular Access Device Market Overview
Aging Population Driving Demand :
Japan's rapidly aging demographic, with over 29% of the population aged 65+, significantly increases the prevalence of chronic conditions requiring vascular access devices, particularly for dialysis and chemotherapy administration.
Advanced Healthcare Infrastructure :
Japan's sophisticated healthcare system and high adoption of innovative medical technologies create a favorable environment for premium vascular access solutions and next-generation device implementations.
Renal Disease Prevalence :
High incidence of chronic kidney disease in Japan drives substantial demand for hemodialysis access devices, with approximately 1.3 million patients requiring renal replacement therapy.
Regulatory Excellence :
Japan's stringent regulatory standards and PMDA approval processes ensure only high-quality vascular access devices reach the market, supporting premium pricing and sustained market growth through 2031.
Japan Vascular Access Device Market Dynamics
- The market is underpinned by Japan's aging population, rising chronic disease burden, and advanced healthcare infrastructure that prioritizes patient outcomes and clinical innovation.
- Increasing investment in dialysis centers and oncology facilities further supports market expansion. Key growth drivers include technological advancements in catheter design, rising awareness of vascular preservation, and improved reimbursement policies.
- However, market growth remains slightly below the global 6.7% CAGR due to Japan's mature healthcare market and stringent regulatory environment.
- Strategic partnerships between domestic manufacturers and international players will be critical for capturing emerging opportunities in minimally invasive access solutions..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- CONMED Corporation
Key Takeaways
- Japan's vascular access device market will grow from USD 175.6 million in 2026 to USD 230.2 million by 2031 at a 5.6% CAGR.
- Japan's aging demographic and high prevalence of end-stage renal disease drive sustained demand for vascular access solutions.
- Japan's advanced healthcare system and regulatory framework support adoption of innovative, minimally invasive vascular access technologies.
- Japan's market growth is supported by expanding dialysis centers and oncology facilities requiring reliable central and peripheral access devices.
Vascular Access Device Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | SUBCUTANEOUS (Route Of Insertion) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 6.7% from 2026 to 2031 |
| Largest Segment | INTRAVENOUS (Route Of Insertion) |
| Market Size Base Year (Billions) | ~USD 6.29 (2026) |
| Revenue Forecast (Billions) | ~USD 8.7 (2031) |
| Segments Covered | Type, Route Of Insertion, Application, End User |
Japan Vascular Access Device Market Report Segmentation
4 segment dimensions are covered across the global market.
By Type
- Accessories
- Butterfly/Winged Steel Needles
- Central Venous Access Devices
- Chemotherapy
- Implantable Conventional Ports
- Implantable Ports
- Implantable Power Injectable Ports
- Integrated/Accelerated Midline Catheters
- Intraosseous Vascular Access Devices
- Midline Catheters
- Mst Max Barrier Midline Catheters
- Non-Tunneled Catheters
- Other Drug Administration Applications
- Peripheral Arterial Access Devices
- Peripheral Intravenous Catheters
- Peripheral Vascular Access Devices
- Peripheral Venous Access Devices
- Peripherally Inserted Central Catheters
- Private
- Public
- Tunneled Catheters
By Route Of Insertion
- Intraosseous
- Intravenous
- Subcutaneous
By Application
- Blood Transfusion
- Diagnostics & Testing
- Drug Administration
- Fluid & Nutrition Administration
By End User
- Ambulatory Care Centers
- Clinics
- Hospitals
- Other End Users
JAPAN: VASCULAR ACCESS DEVICE MARKET, BY END USER, 2024–2031
| Segment | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| AMBULATORY CARE CENTERS | 63.3 | 67.6 | 71.6 | 75.9 | 80.9 | 86.4 | 92.4 | 99.1 | 6.7 |
| CLINICS | 42.7 | 45.4 | 47.9 | 50.6 | 53.6 | 57 | 60.7 | 64.7 | 6.2 |
| HOSPITALS | 149.8 | 158.5 | 166.2 | 174.5 | 184 | 194.6 | 206.2 | 218.8 | 5.7 |
| OTHER END USERS | 31.4 | 33.4 | 35.2 | 37.1 | 39.3 | 41.7 | 44.4 | 47.3 | 6.1 |
| TOTAL | 287.2 | 305 | 321 | 338.1 | 357.8 | 379.7 | 403.6 | 429.9 | 6 |
Target Audience
- Medical Device Manufacturers : Manufacturers seeking to enter or expand in Japan's vascular access market need localized market intelligence, regulatory requirements, and competitive positioning data to optimize product launches and market penetration strategies.
- Healthcare Facility Operators : Dialysis centers, hospitals, and oncology clinics in Japan require market trend analysis and device performance data to make informed procurement decisions and optimize patient care delivery.
- Investment & Private Equity Firms : Investors evaluating opportunities in Japan's healthcare sector need comprehensive market sizing, growth projections, and competitive dynamics to assess investment viability and portfolio company potential.
- Healthcare Consultants & Advisors : Consulting firms advising clients on market entry, product strategy, or M&A activities in Japan require detailed market segmentation, regulatory insights, and competitive intelligence specific to vascular access devices.
- Government & Policy Organizations : Japanese healthcare policymakers and regulatory bodies benefit from market data to inform reimbursement policies, healthcare infrastructure planning, and innovation incentive programs for vascular access solutions.
Key Companies in the Japan Vascular Access Device Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| PENUMBRA, INC. | United States | Public Company | Neurovascular thrombectomy (Penumbra System, RED, JET, ACE, ENGINE, 3D Revascularization Device),Peripheral thrombectomy (Indigo, Lightning Flash, Lightning Bolt 7, CAT RX),Neuro and peripheral embolization (Ruby platforms, POD, coils, LANTERN, Packing Coil), |
| SANOFI | France | Public Company | Pediatric and Combination Vaccines (including hexavalent),Other Vaccines (RSV, travel, rabies, yellow fever, typhoid, hepatitis A),Immunology & Inflammation Therapies, |
| BECTON, DICKINSON AND COMPANY | United States | Public Company | Medical Essentials (syringes, needles, IV and vascular access, sharps, basic disposables),Connected Care (infusion, medication management, pharmacy automation, informatics, hemodynamic monitoring),BioPharma Systems (prefillable drug delivery systems and related services), |
| TERUMO CORPORATION | Japan | Public Company | Cardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company, |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular access and emergency medicine (Arrow, EZ-IO, QuikClot, FAST1),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),Interventional cardiology and peripheral (GuideLiner, Turnpike, TrapLiner, MANTA, DCBs, stents, balloons), |
| ICU MEDICAL INC. | United States | Public Company | IV solutions and diluents,Infusion pumps and hardware,Vascular access and needlefree connectors, |
| MERIT MEDICAL SYSTEMS | United States | Public Company | Cardiovascular – Peripheral Intervention (angiography, drainage, delivery, embolotherapy),Cardiovascular – Cardiac Intervention (access, EP/CRM, fluid management, hemodynamic, hemostasis),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy), |
| NIPRO CORPORATION | Japan | Public Company | Renal care (hemodialysis machines, dialyzers, blood tubing sets),Injection and infusion (syringes, catheters, IV sets),Glass pharma packaging and components, |
| ANGIODYNAMICS | United States | Public Company | Med Tech (Auryon, AlphaVac, AngioVac, NanoKnife, Solero, VenaCure EVLT),Med Device (peripheral catheters, guidewires, ports, drainage, micropuncture kits), |
| AMECATH | Egypt | Private Company | Dialysis catheters,Central venous and midline catheters,Urology catheters, |
PENUMBRA, INC.
PENUMBRA, INC. is a United States-based public company founded in 2004 with 4700 employees.
SANOFI
SANOFI is a French public company founded in 1994 with 74846 employees.
BECTON, DICKINSON AND COMPANY
BECTON, DICKINSON AND COMPANY is a United States-based public company founded in 1897 with 72000 employees.
TERUMO CORPORATION
TERUMO CORPORATION is a Japanese public company founded in 1921 with 30591 employees.
TELEFLEX INCORPORATED
TELEFLEX INCORPORATED is a United States-based public company founded in 1943 with 15500 employees.
ICU MEDICAL INC.
ICU MEDICAL INC. is a United States-based public company founded in 1984 with 13000 employees.
MERIT MEDICAL SYSTEMS
MERIT MEDICAL SYSTEMS is a United States-based public company founded in 1987 with 7500 employees.
NIPRO CORPORATION
NIPRO CORPORATION is a Japanese public company founded in 1954.
ANGIODYNAMICS
ANGIODYNAMICS is a United States-based public company founded in 1988 with 632 employees.
AMECATH
AMECATH is an Egypt-based private company founded in 1991.
Reasons to Buy this Report
- Demographic-Specific Insights : Understand how Japan's unique aging population structure and high prevalence of renal disease create distinct market dynamics and growth opportunities compared to other developed nations.
- Regulatory Pathway Clarity : Gain detailed knowledge of PMDA approval processes, Japanese reimbursement structures, and compliance requirements essential for successfully launching or expanding vascular access device portfolios in Japan.
- Competitive Landscape Analysis : Identify key domestic and international competitors operating in Japan's market, their market share, product positioning, and strategic initiatives to inform competitive strategy.
- Market Sizing & Forecasting : Access precise market valuation data (USD 175.6M in 2026, USD 230.2M in 2031) with segment breakdowns by device type, application, and end-user to support investment and expansion decisions.
- Growth Driver Identification : Understand specific catalysts driving Japan's 5.6% CAGR, including healthcare infrastructure investments, technological adoption rates, and clinical practice shifts unique to the Japanese market.
Frequently asked questions
What is the current size of Japan's vascular access device market?
Japan's vascular access device market is valued at USD 175.6 million in 2026.
What is the projected market size for vascular access devices in Japan by 2031?
Japan's vascular access device market is projected to reach USD 230.2 million by 2031.
What is the growth rate of Japan's vascular access device market?
Japan's vascular access device market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2031.
What factors are driving growth in Japan's vascular access device market?
Key drivers include Japan's aging population, rising prevalence of chronic kidney disease and cancer, expanding dialysis infrastructure, and adoption of minimally invasive procedures.
Which vascular access device types are most commonly used in Japan?
Japan's market includes arteriovenous fistulas, tunneled central venous catheters, and peripheral inserted central catheters (PICCs), with adoption driven by clinical efficacy and patient safety standards.
RESEARCH METHODOLOGY
Secondary research was conducted to gather information for this technical, market-oriented, and commercial study of the global vascular access device (VAD) market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Different approaches, such as top-down and bottom-up, were used to estimate the total market size. After that, market breakup and data triangulation procedures were used to estimate the size of the segments and subsegments of the VAD market.
Secondary Research
In the secondary research process, various secondary sources were consulted to identify and collect information for the study. These sources included annual reports, press releases, and investor presentations of device manufacturers; regulatory filings and clearance databases; clinical literature and peer-reviewed journals; healthcare and infection-control association publications; certified publications; and white papers. Secondary research was primarily used to obtain key information on the industry's supply chain, the total pool of key players, market classification and segmentation according to industry trends down to the most granular level, regional markets, and key developments from both market- and technology-oriented perspectives. All of this information was further validated by primary sources.
Primary Research
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report: marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the vascular access device market. Primary sources on the demand side include directors and presidents of hospitals & cardiac centers, as well as scientists/researchers from academic & research institutes. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends and dynamics.
In the market engineering process, top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was conducted throughout the market engineering process to present key information and insights throughout the report.
After the complete market engineering process—including calculations for market statistics, market breakups, market size estimates, market forecasts, and data triangulation—extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. Primary research was also used to identify segmentation types, industry trends, the competitive landscape among VAD market players, and key market dynamics, including drivers, restraints, opportunities, challenges, and key strategies.
Note 2: Tier 1 companies – revenue higher than USD 10 billion; Tier 2 companies – revenue between USD 1 and 10 billion; Tier 3 companies – revenue between USD 500 million and USD 1 billion.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Top-down and bottom-up approaches were used to estimate and validate the size of the VAD market and the sizes of various dependent subsegments within the overall market. The research methodology used to estimate market size included identifying key market players through secondary research and determining their market shares in each region through both primary and secondary research. This entire procedure included the study of the annual and financial reports of the top market players, and extensive interviews were conducted with key industry leaders, such as CEOs, VPs, directors, and marketing executives, to gain key insights.
All percentage splits and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the market covered in this research study have been accounted for, examined in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data. This data is consolidated and combined with detailed input and analysis from MarketsandMarkets.
Data Triangulation
After determining the overall market size using the market size estimation processes explained above, the market was segmented into several segments and subsegments. Data triangulation and market breakup procedures were employed, where applicable, to complete the overall market engineering process and obtain the exact statistics for each market segment and subsegment. The data was triangulated by analyzing various factors and trends from both the demand and supply sides.
Market Definition
A vascular access device (VAD) is a medical device used to gain access to a patient's bloodstream for the administration of drugs, fluids, blood products, and nutrition, as well as for blood sampling and diagnostic procedures. VADs include peripheral devices (such as peripheral intravenous catheters, midline catheters, and arterial catheters), central devices (such as peripherally inserted central catheters, centrally and non-tunneled/tunneled central venous catheters, and implantable ports), and intraosseous access systems, along with related accessories. These devices incorporate features such as safety-engineered designs, antimicrobial and antithrombogenic coatings, and compatibility with ultrasound-guided insertion to ensure safe, reliable, and repeatable vascular access across hospital, ambulatory, and home-care settings.
Key Stakeholders
- Vascular access device manufacturers and suppliers
- Hospitals, clinics, and ambulatory care centers
- Clinicians (interventional radiologists, vascular access nurses, anesthesiologists, and intensivists)
- Hospital procurement teams and group purchasing organizations (GPOs)
- Infection-prevention and patient-safety professionals
- Distributors, dealers, and contract manufacturers
- Regulatory authorities and healthcare standards organizations
- Research institutes and academic medical centers
- Investors and technology partners
Report Objectives
- To describe and forecast the global vascular access device market by type, route of insertion, application, end user, and region from 2026 to 2031, and to analyze the various macroeconomic and microeconomic factors that affect market growth.
- To forecast the market size of five main regions: North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.
- To analyze the subsegments of the market with respect to individual growth trends, prospects, and contributions to the overall market.
- To provide detailed information regarding the major factors (drivers, restraints, opportunities, and challenges) influencing market growth.
- To analyze opportunities in the market for stakeholders and to provide details of the competitive landscape of major players.
- To profile key market players and comprehensively analyze their business overviews, regional presence, product offerings, business strategies, and key financials, and to illustrate the competitive landscape of the market.
- To analyze competitive developments such as mergers & acquisitions, product launches, partnerships and collaborations, and research & development (R&D) activities in the market.
Available customizations:
With the provided market data, MarketsandMarkets offers customizations tailored to company-specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakup of the Rest of Asia Pacific market, by country
- Further breakup of the Rest of Europe market, by country
- Further breakup of the Rest of Latin America market, by country
- Further breakup of the Middle East & African market, by country
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Get the Full Vascular Access Device Market Report
Full forecast, segment splits, and company analysis for all Vascular Access Device Market.
- US Vascular Access Device Market
- Canada Vascular Access Device Market
- Germany Vascular Access Device Market
- UK Vascular Access Device Market
- France Vascular Access Device Market
- Italy Vascular Access Device Market
- Spain Vascular Access Device Market
- China Vascular Access Device Market
- India Vascular Access Device Market
- Australia Vascular Access Device Market
- South Korea Vascular Access Device Market
- Brazil Vascular Access Device Market
- Mexico Vascular Access Device Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report